Atypical multidrug-resistant APP serotype 1 reported in China

A newly published study from China describes an atypical, multidrug-resistant Actinobacillus pleuropneumoniae serotype 1 isolate tied to a severe farm outbreak, adding a new wrinkle to how veterinarians may need to think about APP surveillance. In the April 2023 outbreak on a Fujian pig farm, affected pigs showed acute respiratory signs, and the event resulted in 30% morbidity and 56% mortality. The isolate, APPFJLYC01, was confirmed as serotype 1, but its toxin-gene pattern did not match the classic expectation for that serotype. (frontiersin.org)

That matters because APP remains one of the most consequential bacterial respiratory pathogens in swine production worldwide, and its virulence is closely linked to Apx toxins. A recent Frontiers review notes that serotype distribution varies geographically and that cross-protection between serotypes is limited. The same review describes ApxI as strongly hemolytic and cytotoxic, ApxIII as highly cytotoxic but non-hemolytic, and ApxIV as a conserved marker expressed in infected pigs. (frontiersin.org)

In the new paper, the Fujian isolate carried ApxII, ApxIII, and ApxIV, while lacking ApxI, which the authors say differs from the typical serotype 1 pattern of ApxI, ApxII, and ApxIV. The strain was also resistant to six tested antimicrobials: polymyxin, tetracycline, enrofloxacin, ampicillin, gentamicin, and amoxicillin/clavulanic acid. In mouse testing, the isolate was still virulent, though the authors characterized it as having relatively low virulence in that model. The same strain has also been the subject of a 2025 PLOS One genomic analysis, which linked the outbreak to 70-day-old pigs and positioned the work as relevant to antimicrobial and vaccine selection. (frontiersin.org)

The report also fits into a wider pattern of change in China’s APP epidemiology. In a separate 2026 study covering 90 Chinese APP clinical isolates collected from 20 provinces between 2021 and 2024, investigators found that serovar 15 had become predominant, while previously common serovars 1 and 7 had fluctuated or declined. That study also found high resistance rates to doxycycline and florfenicol, and a sharp increase in multidrug-resistant isolates over the study period, from 0% in 2021 to 42.1% in 2024. (journal.hep.com.cn)

There’s also some international context for the “atypical” label. A 2026 report from Japan described atypical APP serovar 1 isolates that created serologic typing challenges because of defects in capsular polysaccharide production, even though those Japanese isolates had a different atypical feature than the Chinese strain. Taken together, the papers suggest that APP variants may emerge in more than one way — through altered toxin profiles, altered capsule expression, or both — and that conventional expectations around serotype behavior may not always hold. That inference is based on comparison of the two studies, not on a direct claim from either research group. (frontiersin.org)

Why it matters: For veterinary professionals, especially those in swine practice, the practical takeaway is that APP diagnostics and treatment decisions may need to become more data-driven at the farm level. If atypical toxin profiles are circulating, assumptions about virulence, expected lesions, or vaccine fit based only on serotype may be less reliable. And if multidrug resistance is increasing, empiric antimicrobial choices become riskier. That aligns with broader animal health concerns around antimicrobial resistance highlighted by WOAH, which has framed resistant pathogens as a growing One Health threat. (frontiersin.org)

For herd veterinarians, this supports a familiar but increasingly important workflow: prioritize culture and susceptibility testing during outbreaks, review vaccine strategy against currently circulating serotypes, and interpret lab results with an eye toward possible atypical APP biology. It may also be worth watching whether diagnostic labs begin reporting more unusual toxin-gene combinations, especially in regions where APP serotype patterns are already shifting. (frontiersin.org)

What to watch: The next key question is whether additional field isolates with this serotype 1/ApxIII pattern turn up in China or elsewhere, and whether future genomic and challenge studies show meaningful effects on transmission, pathogenicity in pigs, serologic typing, or vaccine performance. (frontiersin.org)